TP53 and metastatic malignant neoplasm in the lymph nodes: TP53 was strongly correlated with the presence of lymph node metastases, as demonstrated by logistic regression analysis, with an odds ratio (OR) of 7.3 (95% CI: 2.2–24.6, p = 0.001; Nagelkerke’s R2 = 0.262).